Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The primary analysis was done using intention-to-treat ANCOVA estimation with missing data derived from the placebo pool
Abstract This technical note demonstrates a sensitive method to quantify a glucagon-like peptide-1 (GLP-1) analog, semaglutide, in rat plasma on a high-end triple quadrupole mass spectrometer
Not intended for human, veterinary or therapeutic use under any circumstances
The procedure is relatively quick, often taking around 5 minutes
Exclusion criteria included combination therapy, insulin as first-line treatment, and diabetes secondary to other causes
US$ 28.27
US$ 25.41
US$ 27.40
US$ 26.88
US$ 26.60
US$ 22.62
US$ 26.04
US$ 22.71
US$ 21.31
